Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added, and the government funding notice along with Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding lapse notice was added to the page. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study content or layout are evident.SummaryDifference0.0%

- Check49 days agoChange DetectedPublications section updated with a PubMed citation: Wang H, Yuan S, Wang H. Current Status of Research on Losartan in Tumour Therapy. J Cell Mol Med. 2026 Jan;30(1):e70985. Notes indicate the entry is automatically filled from PubMed and may not be about the study.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded Location sections for Colorado, District of Columbia, Maryland, Massachusetts, New York, and Texas, and updated the page revision to v3.3.3; removed the previous location blocks (v3.3.2).SummaryDifference0.6%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.